Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome

BACKGROUND: Sjögren’s syndrome (SjS), one of the most common autoimmune diseases, impacts millions of people annually. SjS results from autoimmune attack on exocrine (salivary and lacrimal) glands, and women are nine times more likely to be affected than men. To date, no vaccine or therapeutic exist...

Descripción completa

Detalles Bibliográficos
Autores principales: Akgul, Ali, Maddaloni, Massimo, Jun, Sang Mu, Nelson, Andrew S., Odreman, Vanessa Aguilera, Hoffman, Carol, Bhagyaraj, Ella, Voigt, Alexandria, Abbott, Jeffrey R., Nguyen, Cuong Q., Pascual, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022426/
https://www.ncbi.nlm.nih.gov/pubmed/33823920
http://dx.doi.org/10.1186/s13075-021-02475-1
_version_ 1783674924882198528
author Akgul, Ali
Maddaloni, Massimo
Jun, Sang Mu
Nelson, Andrew S.
Odreman, Vanessa Aguilera
Hoffman, Carol
Bhagyaraj, Ella
Voigt, Alexandria
Abbott, Jeffrey R.
Nguyen, Cuong Q.
Pascual, David W.
author_facet Akgul, Ali
Maddaloni, Massimo
Jun, Sang Mu
Nelson, Andrew S.
Odreman, Vanessa Aguilera
Hoffman, Carol
Bhagyaraj, Ella
Voigt, Alexandria
Abbott, Jeffrey R.
Nguyen, Cuong Q.
Pascual, David W.
author_sort Akgul, Ali
collection PubMed
description BACKGROUND: Sjögren’s syndrome (SjS), one of the most common autoimmune diseases, impacts millions of people annually. SjS results from autoimmune attack on exocrine (salivary and lacrimal) glands, and women are nine times more likely to be affected than men. To date, no vaccine or therapeutic exists to treat SjS, and patients must rely on lifelong therapies to alleviate symptoms. METHODS: Oral treatment with the adhesin from enterotoxigenic Escherichia coli colonization factor antigen I (CFA/I) fimbriae protects against several autoimmune diseases in an antigen (Ag)-independent manner. Lactococcus lactis, which was recently adapted to express CFA/I fimbriae (LL-CFA/I), effectively suppresses inflammation by the induction of infectious tolerance via Ag-specific regulatory T cells (Tregs), that produce IL-10 and TGF-β. To test the hypothesis that CFA/I fimbriae can offset the development of inflammatory T cells via Treg induction, oral treatments with LL-CFA/I were performed on the spontaneous, genetically defined model for SjS, C57BL/6.NOD-Aec1Aec2 mice to maintain salivary flow. RESULTS: Six-week (wk)-old C57BL/6.NOD-Aec1Aec2 mice were orally dosed with LL-CFA/I and treated every 3 wks; control groups were given L. lactis vector or PBS. LL-CFA/I-treated mice retained salivary flow up to 28 wks of age and showed significantly reduced incidence of inflammatory infiltration into the submandibular and lacrimal glands relative to PBS-treated mice. A significant increase in Foxp3(+) and IL-10- and TGF-β-producing Tregs was observed. Moreover, LL-CFA/I significantly reduced the expression of proinflammatory cytokines, IL-6, IL-17, GM-CSF, and IFN-γ. Adoptive transfer of CD4(+) T cells from LL-CFA/I-treated, not LL vector-treated mice, restored salivary flow in diseased SjS mice. CONCLUSION: These data demonstrate that oral LL-CFA/I reduce or halts SjS progression, and these studies will provide the basis for future testing in SjS patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02475-1.
format Online
Article
Text
id pubmed-8022426
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80224262021-04-07 Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome Akgul, Ali Maddaloni, Massimo Jun, Sang Mu Nelson, Andrew S. Odreman, Vanessa Aguilera Hoffman, Carol Bhagyaraj, Ella Voigt, Alexandria Abbott, Jeffrey R. Nguyen, Cuong Q. Pascual, David W. Arthritis Res Ther Research Article BACKGROUND: Sjögren’s syndrome (SjS), one of the most common autoimmune diseases, impacts millions of people annually. SjS results from autoimmune attack on exocrine (salivary and lacrimal) glands, and women are nine times more likely to be affected than men. To date, no vaccine or therapeutic exists to treat SjS, and patients must rely on lifelong therapies to alleviate symptoms. METHODS: Oral treatment with the adhesin from enterotoxigenic Escherichia coli colonization factor antigen I (CFA/I) fimbriae protects against several autoimmune diseases in an antigen (Ag)-independent manner. Lactococcus lactis, which was recently adapted to express CFA/I fimbriae (LL-CFA/I), effectively suppresses inflammation by the induction of infectious tolerance via Ag-specific regulatory T cells (Tregs), that produce IL-10 and TGF-β. To test the hypothesis that CFA/I fimbriae can offset the development of inflammatory T cells via Treg induction, oral treatments with LL-CFA/I were performed on the spontaneous, genetically defined model for SjS, C57BL/6.NOD-Aec1Aec2 mice to maintain salivary flow. RESULTS: Six-week (wk)-old C57BL/6.NOD-Aec1Aec2 mice were orally dosed with LL-CFA/I and treated every 3 wks; control groups were given L. lactis vector or PBS. LL-CFA/I-treated mice retained salivary flow up to 28 wks of age and showed significantly reduced incidence of inflammatory infiltration into the submandibular and lacrimal glands relative to PBS-treated mice. A significant increase in Foxp3(+) and IL-10- and TGF-β-producing Tregs was observed. Moreover, LL-CFA/I significantly reduced the expression of proinflammatory cytokines, IL-6, IL-17, GM-CSF, and IFN-γ. Adoptive transfer of CD4(+) T cells from LL-CFA/I-treated, not LL vector-treated mice, restored salivary flow in diseased SjS mice. CONCLUSION: These data demonstrate that oral LL-CFA/I reduce or halts SjS progression, and these studies will provide the basis for future testing in SjS patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02475-1. BioMed Central 2021-04-06 2021 /pmc/articles/PMC8022426/ /pubmed/33823920 http://dx.doi.org/10.1186/s13075-021-02475-1 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Akgul, Ali
Maddaloni, Massimo
Jun, Sang Mu
Nelson, Andrew S.
Odreman, Vanessa Aguilera
Hoffman, Carol
Bhagyaraj, Ella
Voigt, Alexandria
Abbott, Jeffrey R.
Nguyen, Cuong Q.
Pascual, David W.
Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome
title Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome
title_full Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome
title_fullStr Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome
title_full_unstemmed Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome
title_short Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome
title_sort stimulation of regulatory t cells with lactococcus lactis expressing enterotoxigenic e. coli colonization factor antigen 1 retains salivary flow in a genetic model of sjögren’s syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022426/
https://www.ncbi.nlm.nih.gov/pubmed/33823920
http://dx.doi.org/10.1186/s13075-021-02475-1
work_keys_str_mv AT akgulali stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome
AT maddalonimassimo stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome
AT junsangmu stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome
AT nelsonandrews stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome
AT odremanvanessaaguilera stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome
AT hoffmancarol stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome
AT bhagyarajella stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome
AT voigtalexandria stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome
AT abbottjeffreyr stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome
AT nguyencuongq stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome
AT pascualdavidw stimulationofregulatorytcellswithlactococcuslactisexpressingenterotoxigenicecolicolonizationfactorantigen1retainssalivaryflowinageneticmodelofsjogrenssyndrome